Methylphenidate treats apathy in Parkinson's disease [1]

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 14, Issue 4, 2002, Pages 461-462

  Chatterjee, Anjan ^a   Fahn, Stanley ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; LEVODOPA; METHYLPHENIDATE; PAROXETINE;

AGED; APATHY; BALANCE DISORDER; BEHAVIOR DISORDER; BRADYKINESIA; CASE REPORT; DOPAMINE UPTAKE; DRUG MECHANISM; EMOTION; GAIT DISORDER; HUMAN; LETTER; MAJOR DEPRESSION; MALE; MEMORY DISORDER; MOTIVATION; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0036754180     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.14.4.461     Document Type: Letter

References (13)

1. Howells JG: World History of Psychiatry. New York, Brunner/Mazel, 1975
2. Marin RS: Apathy: A neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 1991; 3:243-254
3. Starkstein SE, Mayberg HS, Preziosi TJ, et al: Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1992; 4:134-139
4. Levy ML, Cummings JL, Fairbanks LA, et al: Apathy is not depression. J Neuropsychiatry Clin Neurosci 1998; 10:314-319
5. Aarsland D, Larsen JP, Lim NG, et al: Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999; 67:492-496
6. Patrick KS, Mueller RA, Gualtieri CT, et al: Pharmacokinetics and actions of methylphenidate, in Psychopharmacology: The Third Generation of Progress, edited by Meltzer HY. New York, Raven, 1987. pp 1387-1395
7. Chiarello RJ, Cole JO: The use of psychostimulants in general psychiatry. Arch Gen Psychiatry 1987; 44:286-295
8. Kaplitz SE: Withdrawn apathetic geriatric patients responsive to methylphenidate. J Am Geriatr Soc 1975; 23:271-276
9. Camicoli R, Lea E, Nutt JG, et al: Methylphenidate increases the motor effects of L-dopa in Parkinson's disease: A pilot study. Clin Neuropharmacol 2001; 24:208-213
10. Persico AM, Reich S, Henningfield JE, et al: Parkinsonian patients report blunted subjective effects of methylphenidate. Exp Clin Psychopharmacol 1998; 6:54-63
11. Mayeux R, Stern Y, Sano M, et al: Clinical and biochemical correlates of bradyphrenia in Parkinson's disease. Neurology 1987; 37:1130-1134
12. Bhatia KP, Marsden CD: The behavioral and motor consequences of focal lesions of the basal ganglia in man. Brain 1994; 117:859-876
13. Cummings JL: Frontal subcortical circuits and human behavior. Arch Neurol 1993; 50:873-880